Skip to content
★ Sign in to follow
JL

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Stock: price and insider trades · China

联环药业

CN·Mcap CN¥3.9BHealth Care

No insider purchase over the last 90 days. The latest, by 王春元, was filed 08 Nov 2024.

Jiangsu Lianhuan Pharmaceutical Co., Ltd.: what insiders have been doing

Only a handful of insider records exist for Jiangsu Lianhuan Pharmaceutical Co., Ltd., the last one from 8 November 2024, too few to describe a trend. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
1
Thresholds
n/a
Buy Volume
€2,223
1 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

  • Filed 08 Nov 2024 · 730 days ago · €2,223
    +98.3%
    Entry CN¥11.26 · Close at T+365 CN¥22.33

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 19,725 of 26,897 companies
35.7
score / 100
Value
29
Quality
42
FCF yld-4.4%
Earn yld2.1%
EV/EBITDA22.3x
ROE-2.2%
Gross mgn49%
Net mgn3.9%
Debt/EBITDA4.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2024

FY ended December 2024 · cache

CN¥13.79
Analyst consensus
·
Income statement
RevenueCN¥2.2B
Gross profitCN¥1.1B49% margin
EBITDACN¥216M10% margin
Net incomeCN¥84.2M-1.6% margin
Valuation
P/Book3.1x
Beta-0.23
Balance sheet & cash
Market capCN¥3.9B
Total debtCN¥883.3M
Free Cash Flow-CN¥174.1M
Debt / Equity103%
Profitability & ownership
ROE-2.2%
ROA-0.2%
% insiders42.4%
% institutions1.0%
Last declaration on 8 November 2024
Declarations1 total
  • ▲
    监事Executives
    17,141 CNY15SSE
    1,500 shares100.0% of flowA股XSHGSSE:173000008241587680
    Canonical exit: 6 Feb 2025 (T+90)

1 of 1 declaration

About Jiangsu Lianhuan Pharmaceutical Co., Ltd.

联环药业 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and production of medicines and pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations